The relationship between concentration of specific antibody at birth and subsequent response to primary immunization

被引:61
作者
Jones, Christine [1 ]
Pollock, Louisa [2 ]
Barnett, Sara M. [1 ]
Battersby, Anna [1 ,2 ]
Kampmann, Beate [1 ,2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Acad Dept Paediat, London W2 1PG, England
[2] Med Res Council Unit Gambia, Banjul, Gambia
基金
英国惠康基金;
关键词
Vaccine; Infant; Immune response; MATERNAL ANTIBODIES; PERTUSSIS-VACCINE; HOUSEHOLD EXPOSURE; IGG ANTIBODIES; IMMUNOGENICITY; TETANUS; INFANTS; MEASLES; CONJUGATE; POLYSACCHARIDE;
D O I
10.1016/j.vaccine.2013.11.104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and aims: Trans-placentally acquired antibodies can protect infants from infection in the first months of life. However, high concentrations of antibody at birth may impact the infant's own immune response to primary immunization. We examine the relationship between concentration of specific antibody to Bordetella pertussis, Haemophilus influenzae type b (Hib), tetanus toxoid and pneumococcal antigens at birth and following primary immunization. Methods: Healthy mother-infant pairs were recruited from a UK maternity unit Peripheral blood samples were obtained at birth and 4 weeks after primary immunization. Specific antibody concentrations were determined using enzyme-linked immunosorbent assays. Pertussis antibody concentrations >50 IU/ml, Tetanus antibody levels >0.1 IU/ml and Hib antibody levels >0.15 mg/l were regarded as protective. Results: Following primary immunization, 35/36 (97%) infants had specific antibody concentrations associated with protection against Hib, 32/36 (89%) against pertussis and 36/36 (100%) against tetanus. Concentrations of all specific antibodies were significantly higher than at birth (p < 0.0001), except anti-tetanus toxoid,p = 0.41. However, there was an inverse correlation between infant antibody concentration at birth and fold-increase in antibody concentration post-immunization for tetanus: r(s) -0.86 (95%CI -0.93 to -0.74),p < 0.0001; pneumococcus: r(s) -0.82 (95% CI -0.91 to -0.67),p < 0.0001; pertussis: r(s) -0.77 (95% CI -0.89 to -0.58),p < 0.0001 and Hib: r(s) -0.66 (95%CI -0.82 to -0.42),p < 0.0001. The highest concentrations of specific IgG at birth were associated with lower concentrations post-immunization for tetanus (p = 0.009) and pneumococcus (p = 0.03). This association was not observed for Hib (p = 0.88) or pertussis (p = 0.14). Conclusion: Higher antibody concentration at birth appeared to inhibit the response to infant immunization for tetanus and pneumococcus; the effect was less marked for Hib and pertussis. However, the majority of infants achieved high antibody levels post-immunization. This supports maternal immunization, as high levels of maternally derived antibody at birth may not inhibit infants' immunization responses in a clinically relevant manner. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:996 / 1002
页数:7
相关论文
共 39 条
[1]  
Abel J, 2013, P OBSTET GYNAECOLOGY, V3, P8
[2]   AVIDITY OF SPECIFIC IGG ANTIBODIES ELICITED BY IMMUNIZATION AGAINST HAEMOPHILUS-INFLUENZAE TYPE-B [J].
AGBARAKWE, AE ;
GRIFFITHS, H ;
BEGG, N ;
CHAPEL, HM .
JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (03) :206-209
[3]   PERSISTENCE OF MATERNAL ANTIBODY IN INFANTS BEYOND 12 MONTHS - MECHANISM OF MEASLES-VACCINE FAILURE [J].
ALBRECHT, P ;
ENNIS, FA ;
SALTZMAN, EJ ;
KRUGMAN, S .
JOURNAL OF PEDIATRICS, 1977, 91 (05) :715-718
[4]  
AMINO N, 1978, OBSTET GYNECOL, V52, P415
[5]  
[Anonymous], 2006, WEEKLY EPIDEMIOLOGIC, V81, P197
[6]   Immunogenicity of a three-component acellular pertussis vaccine administered at birth [J].
Belloni, C ;
De Silvestri, A ;
Tinelli, C ;
Avanzini, MA ;
Marconi, M ;
Strano, F ;
Rondini, G ;
Chirico, G .
PEDIATRICS, 2003, 111 (05) :1042-1045
[7]   Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination? [J].
Beyer, WEP ;
Palache, AM ;
Lüchters, G ;
Nauta, J ;
Osterhaus, ADME .
VIRUS RESEARCH, 2004, 103 (1-2) :125-132
[8]   Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine [J].
Blanchard-Rohner, Geraldine ;
Watt, Hilary ;
Kelly, Dominic F. ;
Yu, Ly-Mee ;
Snape, Matthew D. ;
Pollard, Andrew J. .
VACCINE, 2012, 30 (28) :4153-4159
[9]   IMMUNOGENICITY OF COMBINED DIPHTHERIA, TETANUS, AND PERTUSSIS-VACCINE GIVEN AT 2, 3, AND 4 MONTHS VERSUS 3, 5, AND 9 MONTHS OF AGE [J].
BOOY, R ;
AITKEN, SJM ;
TAYLOR, S ;
TUDORWILLIAMS, G ;
MACFARLANE, JA ;
MOXON, ER ;
ASHWORTH, LAE ;
MAYONWHITE, RT ;
GRIFFITHS, H ;
CHAPEL, HM .
LANCET, 1992, 339 (8792) :507-510
[10]   SEROLOGICAL RESPONSE TO FILAMENTOUS HEMAGGLUTININ AND LYMPHOCYTOSIS-PROMOTING TOXIN OF BORDETELLA-PERTUSSIS [J].
BURSTYN, DG ;
BARAFF, LJ ;
PEPPLER, MS ;
LEAKE, RD ;
STGEME, J ;
MANCLARK, CR .
INFECTION AND IMMUNITY, 1983, 41 (03) :1150-1156